New technology that rapidly and simply detects disease-specific molecular alterations in two forms of leukemia could give ...

Rapid blood cancer diagnostics enable faster decision-making, potentially saving lives by providing quicker, more accurate ...

New gene therapies developed using CRISPR gene editing offer the promise of treating or even curing debilitating diseases.

Last year, the Food and Drug Administration (FDA) granted approval for CRISPR's gene therapy for sickle cell disease for ...

Three patients are in “safe, deep remission” after receiving a CRISPR-Cas9-modified cell therapy for autoimmune disease ...

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions.

Six years ago, Sanofi gave $125 million and promised over $1 billion in milestone payments to buzzy neuroscience startup ...

For the biopharma industry to match the pace of genomic innovations and speed new therapies to market, it will need to ...

The treatment, involving the use of donor cells, has shown positive results in patients six months after receiving treatment.

CRISPR Therapeutics ($CRSP), based in Switzerland, commands a lofty valuation when assessing near-term metrics, but the ...

As of October 2024, there are more than thirty FDA-approved gene therapies, spanning a diverse array of diseases such as ...